← All grants
NCI IMAT R61 & R33
NIH National Cancer Institute
Between cycles
Opportunity summary
What we know
Supports translational cancer technology from concept proof to advanced development through NCI.
Last checked 21 July 2026.
Build the right funding mix
Connect grants, investors and strategic programmes around the milestones that matter.
Start your raise